The estimated Net Worth of John Jed Kennedy is at least $2.18 Million dollars as of 3 March 2022. Mr Kennedy owns over 7,714 units of Conmed stock worth over $784,105 and over the last 10 years he sold CNMD stock worth over $821,540. In addition, he makes $572,928 as Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, and Distribution & Customer Service at Conmed.
Mr has made over 22 trades of the Conmed stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 7,714 units of CNMD stock worth $527,560 on 3 March 2022.
The largest trade he's ever made was exercising 30,220 units of Conmed stock on 4 December 2019 worth over $1,333,911. On average, Mr trades about 5,493 units every 101 days since 2015. As of 3 March 2022 he still owns at least 10,687 units of Conmed stock.
You can see the complete history of Mr Kennedy stock trades at the bottom of the page.
John E. Kennedy is the Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service at Conmed.
As the Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, and Distribution & Customer Service of Conmed, the total compensation of Mr Kennedy at Conmed is $572,928. There are 4 executives at Conmed getting paid more, with Curt R. Hartman having the highest compensation of $1,787,620.
Mr Kennedy is 63, he's been the Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, and Distribution & Customer Service of Conmed since . There are 1 older and 8 younger executives at Conmed. The oldest executive at Conmed Corp. is David R. Murray, 73, who is the Pres of ConMed Electrosurgery.
John's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.
Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti, and Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
Conmed executives and other stock owners filed with the SEC include: